Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years
Fred D. Lublin, Stacey S. Cofield, Gary R. Cutter, Tarah Gustafson, Stephen Krieger, Ponnada A. Narayana, Flavia Nelson, Amber R. Salter, Jerry S. Wolinsky
Dive into the research topics of 'Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years'. Together they form a unique fingerprint.